USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Canary Medical Inc.

USPTO PatentsView assignee record - 34 granted patents across 11 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Canary ranks #9,217 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 11 technology areas.

#9,217
of 49,997 US assignees by volume
Top 28%
by Innovation Score (43.6/100)
17.2
avg claims per patent
+633%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9217 · Foreign Corporation #9,217 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 34 grants
  • UPPER-Q #9,217/49,997
  • PHOTO-FINISH Cabela's
  • CPC-FOCUS A61B · 11 areas
  • INNOV-PAR 43.6/100
  • CLAIMS-RICH 17.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +633% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Cabela's LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Canary’s 43.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Canary

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Canary's Innovation Score is 43.6/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Canary?

Each dot is one of Canary’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Canary’s own 17.2 claims/patent is ABOVE the 15.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Canary vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 33.934.034.03434.034.034.1 510152025 Granted patents (volume) Avg claims / patent Clari Inc. - 34, 20.26ClariClay Paky S.p.A. - 34, 15.06Clay Paky S p ACabela's LLC - 34, 7.74Cabela'sCambridge Touch Technologies Ltd. - 34, 18.03Cambridge TouchCanon Information and Imaging Solutions, Inc. - 34, 18.18Canon Information…Canrig Robotic Technologies AS - 34, 15.97Canrig Robotic ASCarebay Europe Ltd - 34, 12.53Carebay EuropeCelldex Therapeutics, Inc. - 34, 14.76Celldex Therapeut…Canary Medical Inc. - 34, 17.18Canary Medical
Canary vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Canary's grants concentrate

Canary Medical Inc. is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (8 grants) versus a trough of 1 in 2018. By volume, Canary sits between Clari Inc. and Celldex Therapeutics, Inc..

Canary's three-year grant acceleration

Canary Medical Inc. shows 14 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Canary's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Canary holds 34 patents at rank #9,228, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Canary

By rank, the assignees closest to #9,228 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Canary's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Canary, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Canary ranks #557 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Canary's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 28% higher than 72% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 20182019202020212022202320242025 9
USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
Canary Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 1 2.9%
2019 2 5.9%
2020 2 5.9%
2021 6 17.6%
2022 1 2.9%
2023 5 14.7%
2024 8 23.5%
2025partial year 9 26.5%

Which technologies does Canary Medical Inc. patent most?

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Canary Medical Inc.'s patent record in context - here's where to go next.

  • Canary Medical Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #9,217 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Canary Medical Inc. against Clari Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.